Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-19 · accession 0000950170-24-129330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-20 | 2024-11-19 | AXSM | Coleman Mark | Dir | M - OptEx | $5.94 | +33.4K | 48.0K | +229% | +$198.5K |
| D | 2024-11-20 | 2024-11-19 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -33.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | M | A | 33,410 | $5.94 | 48,010 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-11-19 | M | D | 33,410 | $0.00 | 0 | D | $5.94 · 2015-06-29 to 2025-06-29 | 33,410 Common Stock |